The evidence base for emergency use authorizations for COVID‐19 treatments: A rapid review

BACKGROUND AND AIMS: During the COVID‐19 pandemic, US Food and Drug Administration (FDA) permitted emergency use authorizations (EUAs) for vaccines/treatments with promising data. Eight treatments were issued EUAs by May 31, 2021; one of these was approved (Remdesivir for certain populations) and tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Knowlson, Catherine, Byrne, Ailish, Wilkinson, Jacqueline, Whitmore, Claire, Torgerson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831114/
https://www.ncbi.nlm.nih.gov/pubmed/36644312
http://dx.doi.org/10.1002/hsr2.1051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831114/
https://www.ncbi.nlm.nih.gov/pubmed/36644312
http://dx.doi.org/10.1002/hsr2.1051

Ejemplares similares